147 related articles for article (PubMed ID: 22735852)
1. Occurrence of killer yeasts in isolates of clinical origin.
Robledo-Leal E; Villarreal-Treviño L; González GM
Trop Biomed; 2012 Jun; 29(2):297-300. PubMed ID: 22735852
[TBL] [Abstract][Full Text] [Related]
2. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
Sangorrín MP; Lopes CA; Rivero A; Caballero AC
Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel killer toxins secreted by wine-related non-Saccharomyces yeasts and their action on Brettanomyces spp.
Mehlomakulu NN; Setati ME; Divol B
Int J Food Microbiol; 2014 Oct; 188():83-91. PubMed ID: 25087208
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the in vitro antimycotic activity of a novel killer protein from Williopsis saturnus DBVPG 4561 against emerging pathogenic yeasts.
Buzzini P; Corazzi L; Turchetti B; Buratta M; Martini A
FEMS Microbiol Lett; 2004 Sep; 238(2):359-65. PubMed ID: 15358421
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimycotic activity of a Williopsis saturnus killer protein against food spoilage yeasts.
Goretti M; Turchetti B; Buratta M; Branda E; Corazzi L; Vaughan-Martini A; Buzzini P
Int J Food Microbiol; 2009 May; 131(2-3):178-82. PubMed ID: 19269052
[TBL] [Abstract][Full Text] [Related]
7. Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts.
Buzzini P; Martini A
Med Mycol; 2001 Dec; 39(6):479-82. PubMed ID: 11798052
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the killer toxin of several yeasts and the purification of a toxin of type K2.
Pfeiffer P; Radler F
Arch Microbiol; 1984 Apr; 137(4):357-61. PubMed ID: 6375620
[TBL] [Abstract][Full Text] [Related]
9. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
10. Biotyping of Candida albicans and other fungi by yeast killer toxins sensitivity.
Polonelli L; Conti S
Methods Mol Biol; 2009; 499():97-115. PubMed ID: 19152043
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Isolates of Candida glabrata Are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae.
Fredericks LR; Lee MD; Eckert HR; Li S; Shipley MA; Roslund CR; Boikov DA; Kizer EA; Sobel JD; Rowley PA
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0245020. PubMed ID: 33972245
[TBL] [Abstract][Full Text] [Related]
12. Interactions between killer yeasts and pathogenic fungi.
Walker GM; McLeod AH; Hodgson VJ
FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
[TBL] [Abstract][Full Text] [Related]
13. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
Testore GP; Dori L; Buonomini AR; Schito GC; Soro O; Fortina G; Andreoni S; Carlone N; Tullio V; Andreoni M
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604
[TBL] [Abstract][Full Text] [Related]
14. Killer toxins of certain yeast strains have potential growth inhibitory activity on gram-positive pathogenic bacteria.
Izgü F; Altinbay D
Microbios; 1997; 89(358):15-22. PubMed ID: 9218351
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of voriconazole against Candida species isolated in Taiwan.
Yang YL; Cheng HH; Lo HJ
Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
[TBL] [Abstract][Full Text] [Related]
16. Killer behaviour in wild wine yeasts associated with Merlot and Malbec type musts spontaneously fermented from northwestern Patagonia (Argentina).
Sangorrín MP; Zajonskovsky IE; Lopes CA; Rodríguez ME; Giraudo de van Broock MR; Caballero AC
J Basic Microbiol; 2001; 41(2):105-113. PubMed ID: 11441458
[TBL] [Abstract][Full Text] [Related]
17. High incidence of sensitivity to yeast killer toxins among Candida and Torulopsis isolates of human origin.
Middelbeek EJ; Hermans JM; Stumm C; Muytjens HL
Antimicrob Agents Chemother; 1980 Mar; 17(3):350-4. PubMed ID: 7191690
[TBL] [Abstract][Full Text] [Related]
18. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
Linares MJ; Charriel G; Solís F; Casal M
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Candida infection. I. Use of killer system for typing of Candida albicans strains.
Budak A
Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):359-67. PubMed ID: 2130801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
